Unlike the usual situation with HBV infection when the virus can be detected in blood samples, hidden or "occult" infection occurs when HBV is only detectable in liver tissues.
What does HBIG stand for?
HBIG stands for HBV (Hepatitis B Virus) Immune Globulin
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of HBIG
We have 1 other meaning of HBIG in our Acronym Attic
- Help for Brain Injured Children (est. 1967; California)
- Hertfordshire Business Incubation Centre (UK)
- History of the Book in Canada (research project)
- House Business and Industry Committee (New Mexico State Legislature)
- Houston Branch of the International Dyslexia Association (Texas)
- House Born Improvised Explosive Device
- Hemophilia Behavioural Intervention Evaluation Projects
- High Bandwidth Instruction Fetching
- Highway and Border Infrastructure Fund (Canada)
- Hispanic Business Initiative Fund
- Hepatitis B Immune Globulin (blood plasma)
- Harry Benjamin International Gender Dysphoria Association, Inc.
- Health and Biomedical Information Network
- Hospital Based Inpatient Psychiatric Services
- Hering Breuer Inflation Reflex
- Hospital-Based In-Patient Rehabilitation
- Harris Bancorp Insurance Services, Inc. (est. 1882)
- Higher Bandwidth Incentive Scheme (Australia)
- Housing Benefit Information System (UK)
- Hoosier Business Investment Tax Credit (Indiana)
Samples in periodicals archive:
1) Sub-Saharan Africa has the largest burden of human immunodeficiency virus (HIV) infections in the world and is also an HBV endemic area.
Age at HBV infection determines the risk of chronicity of disease, with the highest rates developing in perinatally acquired HBV from mothers who are HBeAg positive (90%).
2) In 2002, 103,000 and 53,000 deaths worldwide were estimated to be directly caused by HBV and HCV, respectively.
Prior to the incorporation of HBV vaccination into the Expanded Programme of Immunisation (EPI) more than a decade ago, prevalence rates of HBV were estimated at between 0.
On the other hand, more than 350 million persons are chronic HBV carriers.
Fifteen chapters by researchers from around the world report on research in areas including Hepatitis B vaccine, monotherapy versus combination therapy in patients with chronic HBV, HBV and other blood-borne viral hepatitis infections among drug users, and the immunotherapeutic efficacy of DNA vaccine alone and combined with antiviral drugs.